Target Volume Determination 2015

Selective nodal irradiation in NSCLC: FDG-PET-CT based!

I 44 patients NSCLC I 61.2-64.8 Gy (1.8 Gy BID) I median FU: 16 months I Isolated nodal recurrence: 1 patient (2.3%)

I 88 patients NSCLC I dose-escalation study I median FU: 16 months I Isolated nodal recurrence: 2 patients (2.3%)

Selective nodal irradiation based on PET-CT is safe in NSCLC

De Ruysscher et al ., IJROBP 2005 Belderbos et al ., IJROBP 2006

www.uniklinikum-dresden.de 11